168 related articles for article (PubMed ID: 22768665)
1. Propylthiouracil hepatitis: report of a case and extensive review of the literature.
Memi E; Karras S; Tzotzas T; Krassas GE
J Pediatr Endocrinol Metab; 2012; 25(3-4):331-43. PubMed ID: 22768665
[TBL] [Abstract][Full Text] [Related]
2. A case of autoimmune hepatitis with Graves' disease treated by propylthiouracil.
Sato I; Tsunekawa T; Shinohara Y; Nishio Y; Shimizu Y; Suzuki Y; Yoshioka S
Nagoya J Med Sci; 2011 Aug; 73(3-4):205-9. PubMed ID: 21928702
[TBL] [Abstract][Full Text] [Related]
3. [The clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism].
Lian XL; Bai Y; Dai WX; Jin ZM; Zeng ZP; Guo ZS
Zhonghua Nei Ke Za Zhi; 2004 Jun; 43(6):442-6. PubMed ID: 15312442
[TBL] [Abstract][Full Text] [Related]
4. The onset of antineutrophil cytoplasmic antibody-associated vasculitis immediately after methimazole was switched to propylthiouracil in a woman with Graves' disease who wished to become pregnant.
Kimura M; Seki T; Ozawa H; Ishihara T; Komatsu M; Tajiri S; Yanagi H; Nishina M; Noh JY; Fukagawa M; Takagi A
Endocr J; 2013; 60(3):383-8. PubMed ID: 23154533
[TBL] [Abstract][Full Text] [Related]
5. [Asymptomatic hepatitis induced by propylthiouracil].
De Castro JJ; Nobre EL; Garcia e Costa J; Galvão-Teles A
Acta Med Port; 2001; 14(5-6):523-7. PubMed ID: 11878166
[TBL] [Abstract][Full Text] [Related]
6. Propylthiouracil-induced severe hepatitis: a case report and review of the literature.
Ichiki Y; Akahoshi M; Yamashita N; Morita C; Maruyama T; Horiuchi T; Hayashida K; Ishibashi H; Niho Y
J Gastroenterol; 1998 Oct; 33(5):747-50. PubMed ID: 9773944
[TBL] [Abstract][Full Text] [Related]
7. Gone (from the Physicians' desk reference) but not forgotten: propylthiouracil-associated hepatic failure: a call for liver test monitoring.
Primeggia J; Lewis JH
J Natl Med Assoc; 2010 Jun; 102(6):531-4. PubMed ID: 20575220
[TBL] [Abstract][Full Text] [Related]
8. Rash and cholestatic liver injury caused by methimazole in a woman with Turner syndrome and Graves's disease: a case report and literature review.
Zeng J; Luo F; Lin Z; Chen Y; Wang X; Song Y
BMC Endocr Disord; 2021 Sep; 21(1):179. PubMed ID: 34479513
[TBL] [Abstract][Full Text] [Related]
9. Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves' disease.
Poomthavorn P; Mahachoklertwattana P; Tapaneya-Olarn W; Chuansumrit A; Chunharas A
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1295-301. PubMed ID: 12549809
[TBL] [Abstract][Full Text] [Related]
10. [Propylthiouracil-induced overt hepatic injury in patients with hyperthyroidism].
Lian XL; Bai Y; Dai WX; Guo ZS; Li W; Lu L
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):172-7. PubMed ID: 15171556
[TBL] [Abstract][Full Text] [Related]
11. Propylthiouracil-induced agranulocytosis as a rare complication of antithyroid drugs in a patient with Graves' disease.
Rabelo PN; Rabelo PN; Paula AF; Conceição SAD; Viggiano DPPO; Antunes DE; Jatene EM; Paula SLFM; Dias ML; Reis MAL
Rev Assoc Med Bras (1992); 2019 Jul; 65(6):755-760. PubMed ID: 31340298
[TBL] [Abstract][Full Text] [Related]
12. The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study.
Kim HJ; Kim BH; Han YS; Yang I; Kim KJ; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
Am J Gastroenterol; 2001 Jan; 96(1):165-9. PubMed ID: 11197248
[TBL] [Abstract][Full Text] [Related]
13. The propylthiouracil dilemma.
Glinoer D; Cooper DS
Curr Opin Endocrinol Diabetes Obes; 2012 Oct; 19(5):402-7. PubMed ID: 22820213
[TBL] [Abstract][Full Text] [Related]
14. Hepatotoxicity and cutaneous reactions after antithyroid drug administration.
Otsuka F; Noh JY; Chino T; Shimizu T; Mukasa K; Ito K; Ito K; Taniyama M
Clin Endocrinol (Oxf); 2012 Aug; 77(2):310-5. PubMed ID: 22332800
[TBL] [Abstract][Full Text] [Related]
15. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease.
Hancock LD; Tuttle RM; LeMar H; Bauman J; Patience T
Clin Endocrinol (Oxf); 1997 Oct; 47(4):425-30. PubMed ID: 9404440
[TBL] [Abstract][Full Text] [Related]
16. Severe hepatotoxicity on beginning propylthiouracil therapy.
Lock DR; Sthoeger ZM
J Clin Gastroenterol; 1997 Jun; 24(4):267-9. PubMed ID: 9252857
[TBL] [Abstract][Full Text] [Related]
17. Thyroid function in wholly breast-feeding infants whose mothers take high doses of propylthiouracil.
Momotani N; Yamashita R; Makino F; Noh JY; Ishikawa N; Ito K
Clin Endocrinol (Oxf); 2000 Aug; 53(2):177-81. PubMed ID: 10931098
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Antithyroid Drug-Induced Severe Liver Injury in 18,558 Newly Diagnosed Patients with Graves' Disease in Japan.
Suzuki N; Noh JY; Hiruma M; Kawaguchi A; Morisaki M; Ohye H; Suzuki M; Matsumoto M; Kunii Y; Iwaku K; Yoshihara A; Watanabe N; Sugino K; Ito K
Thyroid; 2019 Oct; 29(10):1390-1398. PubMed ID: 31573408
[No Abstract] [Full Text] [Related]
19. Treatment outcome of Graves' disease in Thai children.
Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
[TBL] [Abstract][Full Text] [Related]
20. Propylthiouracil-induced hemolytic anemia.
Kuo CS; Lin JS; Lin HD
Zhonghua Yi Xue Za Zhi (Taipei); 2001 Dec; 64(12):735-8. PubMed ID: 11922496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
